|
|||||
|
|
Interleukin-2 (IL-2) immunotherapy |
|
| Authors: | M G Macey D H Johnston |
| Affiliation: | Department of Haematology, London Hospital, England, UK. |
| Abstract: | Various forms of immunotherapy have been employed for the treatment of cancer patients during the past 5 years, with recombinant interleukin-2 (IL-2) having been widely used in these treatment regimes. The progress of IL-2 immunotherapy is discussed. |
| Keywords: | |